Widespread conflicts of interest among patient-advocacy organizations uncovered in study

(University of Pennsylvania School of Medicine) Over the past few decades, hundreds of patient-advocacy organizations have emerged in the United States, promoting disease research and influencing FDA and health insurer policies. Now, a new study reveals a large proportion of these organizations have funding or other connections with drug or medical device makers, yet do not adequately disclose the details of these connections or have publicly accessible policies in place describing how they manage them.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2lDFFzy